Recently, HMGB1 was designated an inflammatory marker of cellular senescence and perhaps an important driver of tau pathology in AD (Gaikwad et al., 2021; Gaikwad and Kayed, 2022). The gene discussed is MAPT; the disease is Alzheimer disease.